<?xml version="1.0" encoding="UTF-8"?>
<p id="Par40">A comprehensive harm reduction package needs to be adopted and should include access to new needle and syringe; opioid substitution therapy (OST); HIV services (including HIV prevention counseling, testing an ART); prevention and treatment of STIs; prevention, diagnosis and treatment of TB and viral hepatitis (B and C), risk reduction information and education for PWID and their sex partners, and condom distribution programmes for PWID and their sex partners [
 <xref ref-type="bibr" rid="CR38">38</xref>â€“
 <xref ref-type="bibr" rid="CR40">40</xref>]. Some countries have adopted an integrated harm reduction package to prevent both HIV and hepatitis infection among PWID, given their similar mode of transmission via sexual exposure and high-burden of infection in specific populations [
 <xref ref-type="bibr" rid="CR9">9</xref>, 
 <xref ref-type="bibr" rid="CR36">36</xref>, 
 <xref ref-type="bibr" rid="CR41">41</xref>]. Efforts to promote condom use must specifically address PWID in an environment free to stigma and discrimination [
 <xref ref-type="bibr" rid="CR42">42</xref>].
</p>
